RG
Rikoon Group Portfolio holdings
AUM
$376M
This Quarter Return
+5.23%
1 Year Return
+56.8%
3 Year Return
+63.35%
5 Year Return
–
10 Year Return
–
AUM
$376M
AUM Growth
+$376M
(+4.9%)
Cap. Flow
+$2.36M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
32.1%
Holding
240
New
17
Increased
96
Reduced
53
Closed
6
Top Buys
| 1 |
Eaton
ETN
|
$843K |
| 2 |
NXP Semiconductors
NXPI
|
$353K |
| 3 |
Starbucks
SBUX
|
$328K |
| 4 |
Masco
MAS
|
$312K |
| 5 |
BP
BP
|
$293K |
Top Sells
| 1 |
BCE
BCE
|
$651K |
| 2 |
Stryker
SYK
|
$452K |
| 3 |
Emerson Electric
EMR
|
$416K |
| 4 |
Gilead Sciences
GILD
|
$285K |
| 5 |
Johnson & Johnson
JNJ
|
$282K |
Sector Composition
| 1 | Healthcare | 18.87% |
| 2 | Technology | 14.15% |
| 3 | Industrials | 10.51% |
| 4 | Consumer Staples | 9.8% |
| 5 | Consumer Discretionary | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vanguard FTSE Emerging Markets ETF
VWO
$96.1B
| $628K | 0.17% |
12,072
-27
| -0.2% | -$1.41K |
|
127
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8B
| $616K | 0.16% |
6,046
| – | – |
|
128
Centene
CNC
$14.5B
| $612K | 0.16% |
9,577
+186
| +2% | +$11.9K |
|
129
Lam Research
LRCX
$122B
| $611K | 0.16% |
1,025
| – | – |
|
130
Nike
NKE
$110B
| $608K | 0.16% |
4,566
-204
| -4% | -$27.2K |
|
131
Eli Lilly
LLY
$650B
| $598K | 0.16% |
3,203
+2
| +0.1% | +$373 |
|
132
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $597K | 0.16% |
11,197
+1,000
| +10% | +$53.3K |
|
133
Unilever
UL
$156B
| $588K | 0.16% |
10,539
| – | – |
|
134
Automatic Data Processing
ADP
$122B
| $587K | 0.16% |
3,101
+154
| +5% | +$29.2K |
|
135
Liberty Broadband Class C
LBRDK
$8.72B
| $579K | 0.15% |
3,859
+264
| +7% | +$39.6K |
|
136
Phillips 66
PSX
$53.7B
| $566K | 0.15% |
6,944
-667
| -9% | -$54.4K |
|
137
iShares US Transportation ETF
IYT
$605M
| $515K | 0.14% |
2,000
+300
| +18% | +$77.3K |
|
138
Adobe
ADBE
$147B
| $503K | 0.13% |
1,059
+60
| +6% | +$28.5K |
|
139
Boeing
BA
$179B
| $498K | 0.13% |
1,954
-41
| -2% | -$10.4K |
|
140
Valvoline
VVV
$4.89B
| $497K | 0.13% |
19,052
+3,953
| +26% | +$103K |
|
141
Otis Worldwide
OTIS
$33.6B
| $493K | 0.13% |
7,201
+36
| +0.5% | +$2.47K |
|
142
Mondelez International
MDLZ
$79.7B
| $475K | 0.13% |
8,064
| – | – |
|
143
CRISPR Therapeutics
CRSP
$4.78B
| $464K | 0.12% |
3,812
+365
| +11% | +$44.4K |
|
144
Progressive
PGR
$145B
| $461K | 0.12% |
4,819
-862
| -15% | -$82.5K |
|
145
Sherwin-Williams
SHW
$90.3B
| $460K | 0.12% |
623
+20
| +3% | +$14.8K |
|
146
iShares S&P 500 Value ETF
IVE
$40.9B
| $455K | 0.12% |
3,221
| – | – |
|
147
iShares Russell 2000 Value ETF
IWN
$11.7B
| $451K | 0.12% |
2,825
+5
| +0.2% | +$798 |
|
148
Quest Diagnostics
DGX
$20.3B
| $447K | 0.12% |
3,480
| – | – |
|
149
Gartner
IT
$18.8B
| $443K | 0.12% |
2,425
| – | – |
|
150
Target
TGT
$42.4B
| $436K | 0.12% |
2,203
+39
| +2% | +$7.72K |
|